Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial
NCT07644546
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
350
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
BIOLOGICAL:
IM
Sponsor
National Taiwan University Hospital